Also trades as: 4553.T (JPX) · $vol 3M
TWAPF OTC
Towa Pharmaceutical Co., Ltd.
1W: +0.0%
1M: -1.0%
3M: +52.9%
YTD: +52.9%
1Y: +inf%
3Y: +8.7%
5Y: -48.2%
$25.98
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$478.3B
+1.6% ▲
5Y CAGR: +14.3%
Total Liabilities
$299.1B
-0.0% ▼
5Y CAGR: +18.3%
Shareholders Equity
$179.2B
+4.4% ▲
5Y CAGR: +9.0%
Cash & Investments
$45.6B
+0.3% ▲
5Y CAGR: +14.7%
Total Debt
$228.2B
-1.2% ▼
5Y CAGR: +21.9%
Net Debt
$182.6B
-1.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $32.8B | $24.3B | $29.6B | $45.5B | $45.6B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $32.8B | $24.3B | $29.6B | $45.5B | $45.6B |
| Net Receivables | $50.7B | $54.4B | $71.7B | $61.4B | $74.5B |
| Inventory | $72.7B | $92.9B | $101.1B | $108.3B | $124.2B |
| Other Current Assets | $10.6B | $11.4B | $15.3B | $32.1B | $24.8B |
| Total Current Assets | $166.9B | $183.0B | $217.7B | $247.3B | $269.0B |
| Property, Plant & Equip. | $100.9B | $127.0B | $153.6B | $168.4B | $171.7B |
| Goodwill & Intangibles | $54.1B | $52.9B | $50.6B | $45.8B | $26.8B |
| Long-Term Investments | $1.1B | $1.3B | $3.0B | $3.2B | $1.5B |
| Other Non-Current Assets | $1.9B | $1.8B | $5.7B | $0 | $3.0B |
| Total Non-Current Assets | $163.1B | $188.4B | $212.9B | $223.5B | $209.3B |
| Total Assets | $329.9B | $371.3B | $430.7B | $470.8B | $478.3B |
| — Liabilities — | |||||
| Accounts Payable | $17.0B | $31.3B | $27.0B | $27.0B | $33.6B |
| Short-Term Debt | $64.9B | $22.8B | $13.2B | $22.7B | $30.8B |
| Deferred Revenue | $15.6B | $14.1B | $7.9B | $0 | $0 |
| Other Current Liabilities | $5.3B | $5.5B | $32.5B | $16.5B | $28.3B |
| Total Current Liabilities | $115.1B | $78.5B | $80.1B | $87.9B | $97.5B |
| Long-Term Debt | $79.2B | $150.3B | $189.1B | $195.1B | $184.5B |
| Other Non-Current Liab. | $3.5B | $5.6B | $5.5B | $4.4B | $4.2B |
| Total Non-Current Liabilities | $82.7B | $155.9B | $194.6B | $211.3B | $201.6B |
| Total Liabilities | $197.8B | $234.5B | $274.8B | $299.2B | $299.1B |
| — Equity — | |||||
| Common Stock | $4.7B | $4.7B | $4.7B | $4.7B | $4.7B |
| Retained Earnings | $122.1B | $121.2B | $134.5B | $150.5B | $152.8B |
| Accumulated OCI | $3.1B | $8.7B | $14.5B | $14.2B | $19.4B |
| Total Stockholders Equity | $132.2B | $136.9B | $155.9B | $171.6B | $179.2B |
| Total Liabilities & Equity | $329.9B | $371.3B | $430.7B | $470.8B | $478.3B |
| — Key Metrics — | |||||
| Total Debt | $144.1B | $173.1B | $202.4B | $231.0B | $228.2B |
| Net Debt | $111.3B | $148.8B | $172.7B | $185.5B | $182.6B |
| Total Investments | $1.1B | $1.3B | $3.0B | $3.2B | $1.5B |